Oncogene, 1476-5594

Journal

More filtering options
  1. 2018
  2. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

    Yuan, X., Mu, N., Wang, N., Strååt, K., Sofiadis, A., Guo, Y., Stenman, A., Li, K., Cheng, G., Zhang, L., Kong, F., Lars Ekblad, Johan Wennerberg, Nilsson, I. L., Juhlin, C. C., Larsson, C. & Xu, D., 2018 Sep 4, In : Oncogene.

    Research output: Contribution to journalArticle

  3. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor

    Martuza Sarwar, Syed Khaja, A. S., Aleskandarany, M., Karlsson, R., Althobiti, M., Ødum, N., Mongan, N. P., Nisthman Dizeyi, Johnson, H., Green, A. R., Ellis, I. O., Rakha, E. A. & Jenny L Persson, 2018 Aug 13, In : Oncogene. 15 p.

    Research output: Contribution to journalArticle

  4. Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma

    Li, T., Deng, Y., Shi, Y., Tian, R., Chen, Y., Zou, L., Julhash U. Kazi, Lars Rönnstrand, Feng, B., Chan, S. O., Chan, W. Y., Jianmin Sun & Zhao, H., 2018 Jul 16, In : Oncogene. 15 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment

    A. Ugale, P. Säwén, M. Dudenhöffer-Pfeifer, M. Wahlestedt, Norddahl, G. L. & D. Bryder, 2017, In : Oncogene. 36, p. 3207-3212

    Research output: Contribution to journalArticle

  7. 2016
  8. Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML

    O Lindblad, Cordero, E., Puissant, A., Macaulay, L., Ramos, A., Kabir, N. N., J Sun, J Vallon-Christersson, Haraldsson, K., Hemann, M. T., Åke Borg, F Levander, Stegmaier, K., K Pietras, L Rönnstrand & J U Kazi, 2016 Sep 29, In : Oncogene. 35, 39, p. 5119-5131 13 p.

    Research output: Contribution to journalArticle

  9. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer

    E Englund, M Bartoschek, Reitsma, B., Jacobsson, L., Escudero-Esparza, A., Orimo, A., K Leandersson, C Hagerling, A Aspberg, Storm, P., Okroj, M., H Mulder, K Jirström, K Pietras & A M Blom, 2016, In : Oncogene. 35, 43, p. 5585-5596 12 p.

    Research output: Contribution to journalArticle

  10. 2015
  11. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

    Kobayashi, T., Masoumi, K. & Ramin Massoumi, 2015, In : Oncogene. 34, 17, p. 2251-2260

    Research output: Contribution to journalArticle

  12. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    Busch, S., Acar, A., Magnusson, Y., Gregersson, P., Lisa Rydén & Landberg, G., 2015, In : Oncogene. 34, 1, p. 27-38

    Research output: Contribution to journalArticle

  13. 2014
  14. 2013
  15. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

    Ahlqvist, K., Saamarthy, K., Syed Khaja, A. S., Anders Bjartell & Ramin Massoumi, 2013, In : Oncogene. 32, 12, p. 1601-1608

    Research output: Contribution to journalArticle

  16. MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

    Johansson, J., Berg, T., Kurzejamska, E., Pang, M-F., Tabor, V., Jansson, M., Roswall, P., Kristian Pietras, Sund, M., Religa, P. & Fuxe, J., 2013, In : Oncogene. 32, 50, p. 5614-5624

    Research output: Contribution to journalArticle

  17. 2012
  18. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

    Santo, E. E., Ebus, M. E., Koster, J., Schulte, J. H., Lakeman, A., van Sluis, P., Vermeulen, J., David Gisselsson Nord, Ingrid Øra, Lindner, S., Buckley, P. G., Stallings, R. L., Vandesompele, J., Eggert, A., Caron, H. N., Versteeg, R. & Molenaar, J. J., 2012, In : Oncogene. 31, 12, p. 1571-1581

    Research output: Contribution to journalArticle

  19. The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer

    Brennan, D. J., O'Connor, D. P., Laursen, H., McGee, S. F., McCarthy, S., Zagozdzon, R., Rexhepaj, E., Culhane, A. C., Martin, F. M., Duffy, M. J., Landberg, G., Lisa Rydén, Hewitt, S. M., Kuhar, M. J., Bernards, R., Millikan, R. C., Crown, J. P., Karin Jirström & Gallagher, W. M., 2012, In : Oncogene. 31, 30, p. 3483-3494

    Research output: Contribution to journalArticle

  20. 2011
  21. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

    Storm, P., Sonja Aits, Puthia, M. K., Urbano, A., Northen, T., Powers, S., Bowen, B., Chao, Y., Reindl, W., Lee, D. Y., Sullivan, N. L., Zhang, J., Trulsson, M., Yang, H., Watson, J. D. & Catharina Svanborg, 2011, In : Oncogene. 30, p. 4765-4779

    Research output: Contribution to journalArticle

  22. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

    Kuphal, S., Shaw-Hallgren, G., Eberl, M., Karrer, S., Aberger, F., Bosserhoff, A. K. & Ramin Massoumi, 2011, In : Oncogene. 30, 44, p. 4523-4530

    Research output: Contribution to journalArticle

  23. Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

    Rohlin, A., Engwall, Y., Fritzell, K., Goransson, K., Bergsten, A., Einbeigi, Z., Mef Nilbert, Karlsson, P., Bjork, J. & Nordling, M., 2011, In : Oncogene. 30, 50, p. 4977-4989

    Research output: Contribution to journalArticle

  24. 2010
  25. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    Mestdagh, P. , Fredlund, E. , Pattyn, F. , Rihani, A. , Van Maerken, T. , Vermeulen, J. , Kumps, C. , Menten, B. , De Preter, K. , Schramm, A. , Schulte, J. , Noguera, R. , Schleiermacher, G. , Janoueix-Lerosey, I. , Laureys, G. , Powel, R. , Nittner, D. , Marine, J-C. , Ringnér, M. , Speleman, F. & 1 others Vandesompele, J., 2010, In : Oncogene. 29, 24, p. 3583-3592

    Research output: Contribution to journalArticle

  26. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression

    Iadevaia, V., Caldarola, S., Biondini, L., Gismondi, A., Stefan Karlsson, Dianzani, I. & Loreni, F., 2010, In : Oncogene. 29, 40, p. 5490-5499

    Research output: Contribution to journalArticle

  27. 2009
  28. Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence.

    Attema, J., Kees-Jan Pronk, Norddahl, G., Nygren, J. & David Bryder, 2009, In : Oncogene. 28, p. 2238-2243

    Research output: Contribution to journalArticle

  29. 2008
  30. A novel fusion 5 ' AFF3/3 ' BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma

    Impera, L., Albano, F., Lo Cunsolo, C., Funes, S., Iuzzolino, P., Laveder, F., Panagopoulos, I., Rocchi, M. & Storlazzi, C. T., 2008, In : Oncogene. 27, 47, p. 6187-6190

    Research output: Contribution to journalArticle

  31. 2007
  32. Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.

    Jenny Karlsson, Alexander Pietras, Beckman, S., Pettersson, H., Christer Larsson & Sven Påhlman, 2007, In : Oncogene. 26, 42, p. 6150-6159

    Research output: Contribution to journalArticle

  33. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis

    McBryan, J., Jillian Howlin, Kenny, P. A., Shioda, T. & Martin, F., 2007, In : Oncogene. 26, 44, p. 6406-6419

    Research output: Contribution to journalArticle

  34. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

    Göran B Jönsson, Dahl, C., Johan Staaf, Therese Törngren, Pär-Ola Bendahl, Markus Ringnér, Guldberg, P. & Åke Borg, 2007, In : Oncogene. 26, 32, p. 4738-4748

    Research output: Contribution to journalArticle

  35. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

    Perks, C. M., Vernon, E. G., Ann Rosendahl, Tonge, D. & Holly, J. M. P., 2007, In : Oncogene. 26, 40, p. 5966-5972

    Research output: Contribution to journalArticle

  36. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling

    Herzig, M., Savarese, F., Novatchkova, M., Semb, H. & Christofori, G., 2007, In : Oncogene. 26, 16, p. 2290-2298

    Research output: Contribution to journalArticle

  37. 2006
  38. A gene fusion network in human neoplasia.

    Mattias Höglund, Attila Frigyesi & Felix Mitelman, 2006, In : Oncogene. 25, 18, p. 2674-2678

    Research output: Contribution to journalArticle

  39. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis

    Jillian Howlin, McBryan, J., Napoletano, S., Lambe, T., McArdle, E., Shioda, T. & Martin, F., 2006, In : Oncogene. 25, 10, p. 1532-1542

    Research output: Contribution to journalArticle

  40. Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells.

    Paruchuri, S., Mezhybovska, M., Juhas, M. & Anita Sjölander, 2006, In : Oncogene. 25, 50, p. 6660-6665

    Research output: Contribution to journalArticle

  41. 2005
  42. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.

    Wegiel, B., Anders Bjartell, Ekberg, J., Gadaleanu, V., Brunhoff, C. & Jenny L Persson, 2005, In : Oncogene. 24, 42, p. 6385-6393

    Research output: Contribution to journalArticle

  43. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter

    Cismasiu, V., Adamo, K., Gecewicz, J., Duque, J., Lin, Q. & Avram, D., 2005, In : Oncogene. 24, 45, p. 6753-6764

    Research output: Contribution to journalArticle

  44. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

    Svensson Månsson, S., Karin Jirström, Lisa Rydén, Roos, G., Emdin, S., Ostrowski, M. & Landberg, G., 2005, In : Oncogene. 24, 27, p. 4370-4379

    Research output: Contribution to journalArticle

  45. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.

    Heidenblad, M., David Lindgren, Veltman, J. A., Tord Jonson, Mahlamäki, E. H., Gorunova, L., van Kessel, A. G., Schoenmakers, E. F. P. M. & Mattias Höglund, 2005, In : Oncogene. 24, 10, p. 1794-1801

    Research output: Contribution to journalArticle

  46. The role of Smad signaling in hematopoiesis.

    Jonas Larsson & Stefan Karlsson, 2005, In : Oncogene. 24, 37, p. 5676-5692

    Research output: Contribution to journalReview article

  47. Wnt-5a has tumor suppressor activity in thyroid carcinoma

    Kremenevskaja, N., von Wasielewski, R., Rao, AS., Schofl, C., Tommy Andersson & Brabant, G., 2005, In : Oncogene. 24, 13, p. 2144-2154

    Research output: Contribution to journalArticle

  48. 2004
  49. Microarray expression profiling in melanoma reveals a BRAF mutation signature

    Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, PM., Walker, GJ., Boyle, GM., Harper, U., Cozzi, SJ., Hansen, K., Yudt, L., Schmidt, C., Hersey, P., Ellem, KAO., O'Rourke, MGE., Parsons, PG., Meltzer, P., Markus Ringnér & Hayward, NK., 2004, In : Oncogene. 23, 23, p. 4060-4067

    Research output: Contribution to journalArticle

  50. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.

    Ekberg, J., Landberg, G., Caroline Wigerup, Johan Richter, Wolgemuth, D. J. & Jenny L Persson, 2004, In : Oncogene. 23, 56, p. 9082-9089

    Research output: Contribution to journalArticle

  51. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

    Obad, S., Brunnström, H., Johan Vallon-Christersson, Åke Borg, Kristina Drott & Urban Gullberg, 2004, In : Oncogene. 23, 23, p. 4050-4059

    Research output: Contribution to journalArticle

  52. 2003
  53. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value

    Vandesompele, J., Edsjö, A., De Preter, K., Håkan Axelson, Speleman, F. & Sven Påhlman, 2003, In : Oncogene. 22, 3, p. 456-460

    Research output: Contribution to journalArticle

  54. 2002
  55. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas

    Yang, K., Lui, WO., Xie, YT., Zhang, AJ., Skytting, B., Nils Mandahl, Larsson, C. & Larsson, O., 2002, In : Oncogene. 21, 26, p. 4181-4190

    Research output: Contribution to journalArticle

  56. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers

    Archey, WB., McEachern, KA., Robson, M., Offit, K., Vaziri, SAJ., Casey, G., Åke Borg & Arrick, BA., 2002, In : Oncogene. 21, 46, p. 7034-7041

    Research output: Contribution to journalArticle

  57. SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor

    Ekman, S., Kallin, A., Engström, U., Heldin, C-H. & Lars Rönnstrand, 2002, In : Oncogene. 21, p. 1870-1875

    Research output: Contribution to journalArticle

  58. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

    Loden, M., Stighall, M., Nielsen, HN., Roos, G., Emdin, SO., Ostlund, H. & Landberg, G., 2002, In : Oncogene. 21, 30, p. 4680-4690

    Research output: Contribution to journalArticle

  59. 2001
  60. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Ladanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meindl, A., Argani, P., Healey, J. H., Ueda, T., Yoshikawa, H., Meloni-Ehrig, A., Sorensen, P. H. B., Fredrik Mertens, Nils Mandahl, van den Berghe, H., Sciot, R., Cin, P. & Bridge, J., 2001, In : Oncogene. 20, 1, p. 48-57

    Research output: Contribution to journalArticle

  61. 1999
  62. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein

    Sjöblom, T., Boureux, A., Lars Rönnstrand, Heldin, C-H., Ghysdael, J. & Östman, A., 1999, In : Oncogene. 18, 50, p. 7055-7062

    Research output: Contribution to journalArticle

  63. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding

    Ekman, S., Thuresson, E. R., Heldin, C-H. & Lars Rönnstrand, 1999, In : Oncogene. 18, 15, p. 2481-2488

    Research output: Contribution to journalArticle

Previous 1 2 Next